{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:35:40Z","timestamp":1791034540131,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.brainres.2007.10.029","type":"journal-article","created":{"date-parts":[[2007,10,29]],"date-time":"2007-10-29T16:36:39Z","timestamp":1193675799000},"page":"275-280","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Neuroprotection by early and delayed treatment of acute stroke with high dose Aspirin"],"prefix":"10.1016","volume":"1186","author":[{"given":"Zhao","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2007.10.029_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.brainres.2007.10.029_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/jnnp.60.2.197","article-title":"Aspirin at any dose above 30\u00a0mg offers only modest protection after cerebral ischaemia","volume":"60","author":"Algra","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.brainres.2007.10.029_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.brainres.2003.11.049","article-title":"High-dose aspirin is neuroprotective in a rat focal ischemia model","volume":"998","author":"Berger","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2007.10.029_bib5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0304-3940(03)00029-6","article-title":"Neuroprotective effects of aspirin in patients with acute cerebral infarction","volume":"339","author":"Castillo","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2007.10.029_bib6","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1471-4159.2005.03157.x","article-title":"Aspirin prevention of NMDA-induced neuronal death by direct protein kinase Czeta inhibition","volume":"93","author":"Crisanti","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2007.10.029_bib7","first-page":"623","article-title":"Can COX-2 inhibitor-induced increase in cardiovascular disease risk be modified by essential fatty acids?","volume":"53","author":"Das","year":"2005","journal-title":"J. Assoc. Phys. India"},{"key":"10.1016\/j.brainres.2007.10.029_bib9","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1471-4159.2001.00600.x","article-title":"Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischaemia in rats","volume":"79","author":"De Cristobal","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2007.10.029_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/hs0102.101299","article-title":"Inhibition of glutamate release via recovery of ATP levels accounts for a neuroprotective effect of aspirin in rat cortical neurons exposed to oxygen\u2013glucose deprivation","volume":"33","author":"De Cristobal","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.brainres.2007.10.029_bib10","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0735-1097(01)01289-X","article-title":"Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay","volume":"37","author":"Feldman","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.brainres.2007.10.029_bib11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00001756-199902050-00029","article-title":"Neuroprotective effects of acetylsalicylic acid in an animal model of focal brain ischemia","volume":"10","author":"Khayyam","year":"1999","journal-title":"NeuroReport"},{"key":"10.1016\/j.brainres.2007.10.029_bib12","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1006\/nbdi.2001.0421","article-title":"Attenuation of Zn2+ neurotoxicity by aspirin: role of N-type Ca2+ channel and the carboxyl acid group","volume":"8","author":"Kim","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2007.10.029_bib13","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1179\/016164102101200636","article-title":"Tissue-saving infarct volumetry using histochemistry validated by MRI in rat focal ischemia","volume":"24","author":"Kloss","year":"2002","journal-title":"Neurol. Res."},{"key":"10.1016\/j.brainres.2007.10.029_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-3940(95)11901-8","article-title":"Detection of hydroxyl radicals in rat striatum during transient focal cerebral ischemia: possible implication in tissue damage","volume":"197","author":"Lancelot","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2007.10.029_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","article-title":"Reversible middle cerebral artery occlusion without craniectomy in rats","volume":"20","author":"Longa","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.brainres.2007.10.029_bib16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1227\/00006123-199207000-00014","article-title":"Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model","volume":"31","author":"Menzies","year":"1992","journal-title":"Neurosurgery"},{"key":"10.1016\/j.brainres.2007.10.029_bib17","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1211\/002235702760089054","article-title":"Structural requirements for the neuroprotective effects of aspirin analogues against N-methyl-d-aspartate and zinc ion neurotoxicity","volume":"54","author":"Moon","year":"2002","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.brainres.2007.10.029_bib18","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0028-3908(99)00226-9","article-title":"Mechanisms of the neuroprotective effect of aspirin after oxygen and glucose deprivation in rat forebrain slices","volume":"39","author":"Moro","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2007.10.029_bib19","doi-asserted-by":"crossref","first-page":"14540","DOI":"10.1073\/pnas.95.24.14540","article-title":"Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion","volume":"95","author":"Pillinger","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2007.10.029_bib20","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/01.STR.32.5.1226","article-title":"Delayed neuroprotective effect of insulin-like growth factor-i after experimental transient focal cerebral ischemia monitored with MRI","volume":"32","author":"Schabitz","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.brainres.2007.10.029_bib21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-2007-996108","article-title":"Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis","volume":"23","author":"Schror","year":"1997","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.brainres.2007.10.029_bib22","first-page":"66","article-title":"The future of traditional nonsteroidal antiinflammatory drugs and cyclooxygenase-2 inhibitors in the treatment of inflammation and pain","volume":"57","author":"Sciulli","year":"2005","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.brainres.2007.10.029_bib1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJM199110313251801","article-title":"A comparison of two doses of aspirin (30\u00a0mg vs. 283\u00a0mg a day) in patients after a transient ischemic attack or minor ischemic stroke","volume":"325","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2007.10.029_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0733-8619(18)30241-X","article-title":"Aspirin: dose and indications in modern stroke prevention","volume":"10","author":"van Gijn","year":"1992","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.brainres.2007.10.029_bib24","first-page":"3","article-title":"Mechanism of action of antiinflammatory drugs","volume":"20","author":"Vane","year":"1998","journal-title":"Int. J. Tissue React."},{"key":"10.1016\/j.brainres.2007.10.029_bib25","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/01.STR.0000057813.31798.1F","article-title":"Aspirin inhibits p44\/42 mitogen-activated protein kinase and is protective against hypoxia\/reoxygenation neuronal damage","volume":"34","author":"Vartiainen","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.brainres.2007.10.029_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0022-510X(94)90234-8","article-title":"Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2H) middle cerebral artery occlusion in the rat","volume":"125","author":"Zhang","year":"1994","journal-title":"J. Neurol. Sci."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899307024699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899307024699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,4]],"date-time":"2019-05-04T03:01:39Z","timestamp":1556938899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899307024699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":26,"alternative-id":["S0006899307024699"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2007.10.029","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}